145 related articles for article (PubMed ID: 31636096)
21. Hereditary leiomyomatosis and renal cell cancer syndrome.
Tulandi T; Foulkes WD
CMAJ; 2016 Feb; 188(2):140. PubMed ID: 26323704
[No Abstract] [Full Text] [Related]
22. Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instability.
Lehtonen HJ; Mäkinen MJ; Kiuru M; Laiho P; Herva R; van Minderhout I; Hogendoorn PC; Cornelisse C; Devilee P; Launonen V; Aaltonen LA
Int J Cancer; 2007 Sep; 121(6):1386-9. PubMed ID: 17520677
[TBL] [Abstract][Full Text] [Related]
23. Multiple cutaneous and uterine leiomyomatosis in a 36-year-old female, and discussion of hereditary leiomyomatosis and renal cell carcinoma.
Henley ND; Tokarz VA
Int J Dermatol; 2012 Oct; 51(10):1213-6. PubMed ID: 22994667
[No Abstract] [Full Text] [Related]
24. Multiple cutaneous leiomyomas leading to discovery of novel splice mutation in the fumarate hydratase gene associated with HLRCC.
Tan RYP; Walsh M; Howard A; Winship I
Australas J Dermatol; 2017 Nov; 58(4):e246-e248. PubMed ID: 28266706
[TBL] [Abstract][Full Text] [Related]
25. [Uterine leiomyoma and fumarate hydratase deficiency].
De Jesus J; Boudy AS; Varinot J; Just PA; Bendifallah S; Ilenko A; Daraï É
Gynecol Obstet Fertil Senol; 2019 Mar; 47(3):324-326. PubMed ID: 30497940
[No Abstract] [Full Text] [Related]
26. Case of hereditary leiomyomatosis and renal cell cancer showing multiple cutaneous leiomyomas harboring a recurrent nonsense mutation in the fumarate hydratase gene.
Mai S; Yanagi T; Shimano M; Nishie W; Arita K; Ujiie H
J Dermatol; 2022 Jan; 49(1):e42-e43. PubMed ID: 34755393
[No Abstract] [Full Text] [Related]
27. Fumarate hydratase inactivation in renal tumors: HIF1α, NRF2, and "cryptic targets" of transcription factors.
Ooi A; Furge KA
Chin J Cancer; 2012 Sep; 31(9):413-20. PubMed ID: 22776233
[TBL] [Abstract][Full Text] [Related]
28. Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-Myc.
Sourbier C; Ricketts CJ; Liao PJ; Matsumoto S; Wei D; Lang M; Railkar R; Yang Y; Wei MH; Agarwal P; Krishna M; Mitchell JB; Trepel JB; Neckers L; Linehan WM
Sci Rep; 2019 Dec; 9(1):18409. PubMed ID: 31804603
[TBL] [Abstract][Full Text] [Related]
29. Uterine leiomyomas in hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome can be identified through distinct clinical characteristics and typical morphology.
Uimari O; Ahtikoski A; Kämpjärvi K; Butzow R; Järvelä IY; Ryynänen M; Aaltonen LA; Vahteristo P; Kuismin O
Acta Obstet Gynecol Scand; 2021 Nov; 100(11):2066-2075. PubMed ID: 34480341
[TBL] [Abstract][Full Text] [Related]
30. Hereditary leiomyomatosis and renal cell cancer syndrome: a family affair.
Teh J; Kinnear N; Douglass-Molloy H; Hennessey DB
BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28122802
[TBL] [Abstract][Full Text] [Related]
31. Hereditary leiomyomatosis and renal cell cancer syndrome: An update and review.
Patel VM; Handler MZ; Schwartz RA; Lambert WC
J Am Acad Dermatol; 2017 Jul; 77(1):149-158. PubMed ID: 28314682
[TBL] [Abstract][Full Text] [Related]
32. Prospective Detection of Germline Mutation of Fumarate Hydratase in Women With Uterine Smooth Muscle Tumors Using Pathology-based Screening to Trigger Genetic Counseling for Hereditary Leiomyomatosis Renal Cell Carcinoma Syndrome: A 5-Year Single Institutional Experience.
Rabban JT; Chan E; Mak J; Zaloudek C; Garg K
Am J Surg Pathol; 2019 May; 43(5):639-655. PubMed ID: 30741757
[TBL] [Abstract][Full Text] [Related]
33. Uterine smooth muscle tumors with features suggesting fumarate hydratase aberration: detailed morphologic analysis and correlation with S-(2-succino)-cysteine immunohistochemistry.
Reyes C; Karamurzin Y; Frizzell N; Garg K; Nonaka D; Chen YB; Soslow RA
Mod Pathol; 2014 Jul; 27(7):1020-7. PubMed ID: 24309325
[TBL] [Abstract][Full Text] [Related]
34. Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers.
Muller M; Ferlicot S; Guillaud-Bataille M; Le Teuff G; Genestie C; Deveaux S; Slama A; Poulalhon N; Escudier B; Albiges L; Soufir N; Avril MF; Gardie B; Saldana C; Allory Y; Gimenez-Roqueplo AP; Bressac-de Paillerets B; Richard S; Benusiglio PR
Clin Genet; 2017 Dec; 92(6):606-615. PubMed ID: 28300276
[TBL] [Abstract][Full Text] [Related]
35. Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals.
Forde C; Lim DHK; Alwan Y; Burghel G; Butland L; Cleaver R; Dixit A; Evans DG; Hanson H; Lalloo F; Oliveira P; Vialard L; Wallis Y; Maher ER; Woodward ER
Eur Urol Oncol; 2020 Dec; 3(6):764-772. PubMed ID: 31831373
[TBL] [Abstract][Full Text] [Related]
36. Atypical presentation of Reed syndrome.
Fernández Canga P; Castiñeiras González J; Sánchez Sambucety P
Med Clin (Barc); 2019 Jun; 152(11):468-469. PubMed ID: 30470440
[No Abstract] [Full Text] [Related]
37. The role of metabolic enzymes in mesenchymal tumors and tumor syndromes: genetics, pathology, and molecular mechanisms.
Schaefer IM; Hornick JL; Bovée JVMG
Lab Invest; 2018 Apr; 98(4):414-426. PubMed ID: 29339836
[TBL] [Abstract][Full Text] [Related]
38. Hereditary Leiomyomatosis and Renal Cell Cancer.
Hansen AW; Chayed Z; Pallesen K; Codruta Vasilescu I; Bygum A
Acta Derm Venereol; 2020 Jan; 100(1):adv00012. PubMed ID: 31663596
[TBL] [Abstract][Full Text] [Related]
39. A chemoproteomic portrait of the oncometabolite fumarate.
Kulkarni RA; Bak DW; Wei D; Bergholtz SE; Briney CA; Shrimp JH; Alpsoy A; Thorpe AL; Bavari AE; Crooks DR; Levy M; Florens L; Washburn MP; Frizzell N; Dykhuizen EC; Weerapana E; Linehan WM; Meier JL
Nat Chem Biol; 2019 Apr; 15(4):391-400. PubMed ID: 30718813
[TBL] [Abstract][Full Text] [Related]
40. Pattern multiplicity and fumarate hydratase (FH)/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney tumors without FH gene alteration.
Muller M; Guillaud-Bataille M; Salleron J; Genestie C; Deveaux S; Slama A; de Paillerets BB; Richard S; Benusiglio PR; Ferlicot S
Mod Pathol; 2018 Jun; 31(6):974-983. PubMed ID: 29410489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
